Literature DB >> 16115546

Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages.

Bianca Fuhrman1, Nina Volkova, Michael Aviram.   

Abstract

Macrophage cholesterol accumulation and foam cell formation are the hallmarks of early atherogenesis. Pomegranate juice (PJ) was shown to inhibit macrophage foam cell formation and development of atherosclerotic lesions. The aim of this study was to elucidate possible mechanisms by which PJ reduces cholesterol accumulation in macrophages. J774.A1 macrophages were preincubated with PJ followed by analysis of cholesterol influx [evaluated as LDL or as oxidized LDL (Ox-LDL) cellular degradation], cholesterol efflux and cholesterol biosynthesis. Preincubation of macrophages with PJ resulted in a significant reduction (P<.01) in Ox-LDL degradation by 40%. On the contrary, PJ had no effect on macrophage degradation of native LDL or on macrophage cholesterol efflux. Macrophage cholesterol biosynthesis was inhibited by 50% (P<.01) after cell incubation with PJ. This inhibition, however, was not mediated at the 3-hydroxy-3 methylglutaryl coenzyme A reductase level along the biosynthetic pathway. We conclude that PJ-mediated suppression of Ox-LDL degradation and of cholesterol biosynthesis in macrophages can lead to reduced cellular cholesterol accumulation and foam cell formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115546     DOI: 10.1016/j.jnutbio.2005.02.009

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  16 in total

1.  High intrinsic aerobic capacity and pomegranate juice are protective against macrophage atherogenecity: studies in high- vs. low-capacity runner (HCR vs. LCR) rats.

Authors:  Mira Rosenblat; Nina Volkova; Zaid Abassi; Steven L Britton; Lauren G Koch; Michael Aviram
Journal:  J Nutr Biochem       Date:  2015-05-06       Impact factor: 6.048

2.  Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages.

Authors:  Lili Nimri; Claudia Grajeda-Iglesias; Nina Volkova; Michael Aviram
Journal:  Eur J Nutr       Date:  2018-05-26       Impact factor: 5.614

3.  M1 Macrophages but Not M2 Macrophages Are Characterized by Upregulation of CRP Expression via Activation of NFκB: a Possible Role for Ox-LDL in Macrophage Polarization.

Authors:  Marielle Kaplan; Anna Shur; Yvgeny Tendler
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

4.  Effect of pomegranate juice consumption on biochemical parameters and complete blood count.

Authors:  Eirini Manthou; Kalliopi Georgakouli; Chariklia K Deli; Aggelos Sotiropoulos; Ioannis G Fatouros; Dimitrios Kouretas; Serko Haroutounian; Chrysoula Matthaiou; Yiannis Koutedakis; Athanasios Z Jamurtas
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

5.  Effect of frozen storage on the anthocyanins and phenolic components of pomegranate juice.

Authors:  Hossein Mirsaeedghazi; Zahra Emam-Djomeh; Reza Ahmadkhaniha
Journal:  J Food Sci Technol       Date:  2011-08-24       Impact factor: 2.701

6.  Slfn2 mutation-induced loss of T-cell quiescence leads to elevated de novo sterol synthesis.

Authors:  Ibrahim Omar; Oren Rom; Michael Aviram; Leonor Cohen-Daniel; Abraham K Gebre; John S Parks; Michael Berger
Journal:  Immunology       Date:  2017-08-02       Impact factor: 7.397

7.  Effects of isoflavone-containing soya protein on ex vivo cholesterol efflux, vascular function and blood markers of CVD risk in adults with moderately elevated blood pressure: a dose-response randomised controlled trial.

Authors:  Chesney K Richter; Ann C Skulas-Ray; Jennifer A Fleming; Christina J Link; Ratna Mukherjea; Elaine S Krul; Penny M Kris-Etherton
Journal:  Br J Nutr       Date:  2017-05       Impact factor: 3.718

8.  Pomegranate for your cardiovascular health.

Authors:  Michael Aviram; Mira Rosenblat
Journal:  Rambam Maimonides Med J       Date:  2013-04-30

9.  Pomegranate Protection against Cardiovascular Diseases.

Authors:  Michael Aviram; Mira Rosenblat
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-18       Impact factor: 2.629

10.  Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents.

Authors:  Monica Viladomiu; Raquel Hontecillas; Pinyi Lu; Josep Bassaganya-Riera
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.